Fuse Science reduces strike price of series B warrants to $0.076

Warrants sold in March private placement; price reduced from $0.094

By Devika Patel

Knoxville, Tenn., June 12 - Fuse Science, Inc. reduced the strike price of its series B warrants to $0.076 from $0.094 on June 12, according to an 8-K filed Wednesday with the Securities and Exchange Commission. The warrants were sold in a March private placement.

The Tulsa, Okla., company has developed the rights to sublingual and transdermal delivery systems for bioactive agents that can encapsulate and charge many varying molecules in order to produce complete product formulations, which can bypass the gastrointestinal tract and enter the blood stream directly.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.